Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Researchers from Memorial Sloan Kettering Cancer Center, Department of Surgery detail findings in cancer gene therapy
July 7th, 2009
Researchers detail in 'Relationship between 31P metabolites and oncolytic viral therapy sensitivity in human colorectal cancer xenografts,' new data in cancer gene therapy. According to recent research from the United States, "Studies using phosphorus magnetic resonance spectroscopy (MRS) have pointed to the significance of phospholipid metabolite alterations as biochemical markers for tumor progression or therapy response. Spectroscopic imaging was performed in colorectal flank tumours in nude mice." "In vivo tumor doubling times for each cell line were measured. In vivo sensitivity of each tumor line to treatment with G207 and NV1020 oncolytic viruses was assessed....
Source: Cancer Weekly (2009-07-07)
|
